Florida to Continue Patient Cost-sharing Limits for HIV Drugs in 2017

The AIDS Institute praises the Florida Office of Insurance Regulation (FOIR) for requiring insurers to again limit patient cost-sharing for HIV medications as they submit for review their 2017 Qualified Health Plans (QHPs). In recently released guidance, similar to last year’s, Florida states it will review plans for possible discriminatory practices for medications to treat HIV along with other health conditions. In a new requirement, the State will review formulary adequacy and adverse tiering for certain chronic health conditions, including HIV, hepatitis C, breast and prostate cancer, rheumatoid arthritis, bipolar disorder and schizophrenia, diabetes, and multiple sclerosis.  

To read the full press release, click the link below: 

Attachments: